Altimmune closes $225 million public offering for liver drug development
Go back to Altimmune closes $225 million public offering for liver drug development| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 2.92 +0.05 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.87 | 52 Week High | $54.24 | |||
| Open | $2.84 | 52 Week Low | $48.35 | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.84 | EPS | $0.00 | |||
| Volume | 2,818,683 | |||||
